Plasbumin Solution
Product Images NDC 13533-691

2 FDA label images from Grifols Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Plasbumin (NDC 13533-691). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (13533 691 20 Carton)

Carton Label (13533 691 20 Carton)
Packaging label for Plasbumin-20, Albumin (Human) 20%, USP solution for intravenous infusion. The label shows a 10 g/50 mL strength, and includes storage instructions to keep at room temperature not exceeding 30°C. The product is a single-dose vial, with warnings about use in dehydration and product turbidity. Labeler is Grifols USA, LLC, with prominent branding.*
FDA Label Image

Vial Label (13533 691 21 Vial)

Vial Label (13533 691 21 Vial)
Plasbumin 10 g/50 mL solution, intravenous plasma derivative containing Albumin (Human) 20% USP. The single-dose vial label shows it is for intravenous use only, manufactured by Grifols Therapeutics LLC. The label includes product volume and concentration details, dosing instructions, and warnings about administration timing and product appearance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.